The complicated use of dupilumab in the treatment of atypical generalized pemphigus erythematosus: A report of two cases
Pemphigus is a rare autoimmune disease and has the potential to be fatal without treatment. Pemphigus erythematosus (PE) is a benign type of pemphigus foliaceus. Glucocorticoids and immunosuppressive agents are primary therapeutic modalities in pemphigus erythematosus, which may lead to considerable...
Saved in:
Main Authors: | Jie Chen (Author), Siji Chen (Author), Xia Wu (Author), Xiaoyun Jiang (Author), Yongdong Wang (Author), Hao Cheng (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023) -
Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
by: Angela Y. Moore, MD, et al.
Published: (2023) -
Pemphigus Foliaceus and Pemphigus Erythematosus are the Most Common Subtypes of Pemphigus in Northern Finland
by: Anna-Kaisa Försti, et al.
Published: (2019) -
Pemphigus herpetiformis with atypical features
by: Sukriti Arora, et al.
Published: (2022) -
Atypical Wells syndrome successfully treated with dupilumab
by: Patrick McMullan, et al.
Published: (2023)